-
03 October 2025 07:12:22
- Source: Sharecast

AIM Announcement 3 October 2025
Wellnex Life Limited (ASX/AIM: WNX)
Issue of Shares
Wellnex Life Limited ("Wellnex" or the "Company") (ASX/AIM: WNX), announces the issue of 2,183,948 new ordinary shares of no par value in the Company ("Ordinary Shares") at a reference price of A$0.22 (£0.11) per share, in lieu of cash fees due for capital markets transaction services, including the dual listing on AIM, and investor relations purposes. 1,953,948 of the Ordinary Shares being issued are being issued to Reach Markets Pty Ltd or its nominees.
Admission and Total Voting Rights
Application has been made for admission of the 2,183,948 Ordinary Shares to trading on AIM. It is expected that admission will become effective and dealings in the Ordinary Shares will commence on AIM at 8.00 a.m. on or around 8 October 2025.
The new Ordinary Shares are being issued fully paid and ranking pari passu in all respects with the Company's existing Ordinary Shares.
Following Admission, the Company's issued share capital will comprise of 69,955,476 Ordinary Shares, none of which are held in treasury. Accordingly, the figure of 69,955,476 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules and the provisions of the Company's constitution.
This AIM announcement has been authorised by the Board of Wellnex Life Limited (ASX/AIM:WNX).
For further information, please contact:
Wellnex Life Limited (ASX:WNX) Reach Markets
Zack Bozinovski T: 1300 805 795
Chief Executive Officer & Managing Director E: IR@reachmarkets.com.au
P: +61 3 8399 9419
E: zack.b@wellnexlife.com.au
UK Investors
Strand Hanson (Financial & Nominated Advisor)
James Harris / Richard Johnson Tel: +44 (0) 20 7409 3494
Orana Corporate LLP (Joint Broker) swykeham@oranacorp.com
Sebastian Wykeham
S.P. Angel Corporate Finance LLP (Joint Broker) Tel: +44 (0)20 3470 0470
David Hignell / Vadim Alexandre
To learn more, please visit: www.WellnexLife.com.au/
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.